Taken together,  we see no reason why ISSFAL should  revise its previous (2004) statement on omega-3 fatty acids and cardiovascular disease in light of the Cochrane analysis.

signed   Clemens von Schacky, Medizinische Klinik und Poliklinik Innenstadt, University of Munich, Munich, Germany

              William S Harris, South Dakota Health Research Foundation, University of South Dakota,Sioux Falls , South Dakota ,USA

              Dariush Mozaffarian, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School ,Boston ,MA,USA  

              Penny M. Kris-Etherton, Department of Nutritional Sciences, The Pennsylvania State University, University Park,Pennsylvania,USA

Correspondence to: C. von Schacky, Medizinische Klinik und Poliklinik Innenstadt, University of Munich, Ziemssenstr. 1, D-80336 Munich, Germany. e-mail:

Reference List  

 Hooper L, Thompson RL, Harrison RA, Summerbell CD, Ness AR, Moore HJ, Worthington HV, Durrington PN, Higgins JP, Capps NE, Riemersma RA, Ebrahim SB, Smith GD. Risks and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: systematic review. BMJ. 2006;332:752-760.

    Burr ML, Ashfield-Watt PA, Dunstan FD, Fehily AM, Breay P, Ashton T, Zotos PC, Haboubi NA, Elwood PC. Lack of benefit of dietary advice to men with angina: results of a controlled trial. Eur J Clin Nutr. 2003;57:193-200.

   Bucher HC, Hengstler P, Schindler C, Meier G. N-3 polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials. Am J Med. 2002;112:298-304.

   Burr ML, Fehily AM, Gilbert JF, Rogers S, Holliday RM, Sweetnam PM, Elwood PC, Deadman NM. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet. 1989;2:757-761.